相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications
Michael J. Thorpy et al.
SLEEP MEDICINE (2020)
Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy
Beatrice Setnik et al.
SLEEP (2020)
Long-term health and socioeconomic consequences of childhood and adolescent-onset of narcolepsy
Poul Jennum et al.
SLEEP MEDICINE (2020)
Histamine: neural circuits and new medications
Thomas E. Scammell et al.
SLEEP (2019)
0592 Burden of Narcolepsy: A Survey of Patients and Physicians
Michael J Thorpy et al.
SLEEP (2019)
Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment
Claudio L. A. Bassetti et al.
NATURE REVIEWS NEUROLOGY (2019)
T cells in patients with narcolepsy target self-antigens of hypocretin neurons
Daniela Latorre et al.
NATURE (2018)
Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy
Kiran Maski et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial
Zoltan Szakacs et al.
LANCET NEUROLOGY (2017)
Neural Circuitry of Wakefulness and Sleep
Thomas E. Scammell et al.
NEURON (2017)
The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use
Marta Kollb-Sielecka et al.
SLEEP MEDICINE (2017)
Narcolepsy
Birgitte R. Kornum et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Reducing the Clinical and Socioeconomic Burden of Narcolepsy by Earlier Diagnosis and Effective Treatment
Michael Thorpy et al.
SLEEP MEDICINE CLINICS (2017)
The Humanistic and Economic Burden of Narcolepsy
Natalia M. Flores et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2016)
Narcolepsy
Thomas E. Scammell
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with Modafinil
M. Uguen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
Yves Dauvilliers et al.
LANCET NEUROLOGY (2013)
Health, social, and economic consequences of narcolepsy: A controlled national study evaluating the societal effect on patients and their partners
Poul Jennum et al.
SLEEP MEDICINE (2012)
The histamine H3 receptor: from discovery to clinical trials with pitolisant
Jean-Charles Schwartz
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Histamine H-3 Receptors and Sleep-Wake Regulation
Jian-Sheng Lin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Histamine in the regulation of wakefulness
Mahesh M. Thakkar
SLEEP MEDICINE REVIEWS (2011)
Histamine in the CNS Multiple functions and potential neurologic implications
Eduardo E. Benarroch
NEUROLOGY (2010)
Orexin/Hypocretin and Histamine: Distinct Roles in the Control of Wakefulness Demonstrated Using Knock-Out Mouse Models
Christelle Anaclet et al.
JOURNAL OF NEUROSCIENCE (2009)
Histamine in the nervous system
Helmut L. Haas et al.
PHYSIOLOGICAL REVIEWS (2008)
Health-related quality of life in patients with narcolepsy
Richard Dodel et al.
SLEEP MEDICINE (2007)
BF2.649 [1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H-3 receptor: Preclinical pharmacology
X. Ligneau et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
分享论文
